The Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance is a center for research and education focusing on pathogens that exhibit antimicrobial resistance located at Tufts University and Tufts Medical Center.[1]

History

Tufts University and the Tufts Medical Center founded the Center for Integrated Management of Antimicrobial Resistance (CIMAR) in 2018. The CIMAR was established in order to provide a response to "superbug" epidemics.[2] The founding co-directors of the center were Helen Boucher and Ralph Isberg.[2][3] The center was renamed in honor of Stuart B. Levy in 2020.[4][5] Researchers associated with the Levy CIMAR include Maya Nadimpalli.[6]

References

  1. ↑ "The Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance". Levy CIMAR.
  2. 1 2 "Tufts Medical Center takes on life-threatening superbug infections". Boston Herald. 8 March 2019. Archived from the original on 15 November 2019.
  3. ↑ Gormley, Brian (18 July 2019). "Antibiotics Developers Seek a Cure for Industry Ills". Wall Street Journal.
  4. ↑ "Dedication of the Stuart B. Levy CIMAR at Tufts". www.tuftscimar.org. 21 September 2020. Retrieved 16 January 2021.
  5. ↑ "Remembering Stuart Levy". Tufts Now. 12 September 2019.
  6. ↑ Gewin, Virginia (21 June 2019). "A battle against antibiotic resistance". Nature. doi:10.1038/d41586-019-01962-5. PMID 32561890. S2CID 197829091.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.